What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have significantly improved survival for advanced wild-type non-small cell lung cancer, but there is no direct comparison to confirm which first-line treatment may lead to the longest overall survival. What qualifies as long-term survival (LS) is even...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xue, Xu, Qian, Yu, Xuejun, Huang, Miao, Li, Song, Sheng, Lei, Dai, Xin, Huang, Kai, Wang, Jian, Liu, Lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016897/
https://www.ncbi.nlm.nih.gov/pubmed/35450068
http://dx.doi.org/10.3389/fimmu.2022.764643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016897/
https://www.ncbi.nlm.nih.gov/pubmed/35450068
http://dx.doi.org/10.3389/fimmu.2022.764643

Ejemplares similares